Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
A new study evaluates the association of multiple breast milk feeding practices with infant gut microbiota composition during a baby’s first year.
A new study, published in Cell Metabolism, identified a microbial signature that is able to diagnose cirrhosis in people.
Researchers have found that alterations in the gut microbiota composition in prediabetic people could contribute to type 2 diabetes.
A study published in Nature could help to determine how intestinal motility is regulated and understand systemic disorders related to the gut-brain axis.
To examine the link between autism and gut microbes, researchers led by Anne Konkle at the University of Ottawa analyzed the recent scientific literature.
Researchers have developed molecules that remodel the gut microbiota to a healthier state, reducing cholesterol levels and inhibiting atherosclerosis.
Researchers have developed an approach that uses bacterial biofilms to increase the ability of the gut microbiota to survive and reside in the gastrointestinal tract.
Researchers have found that the gut microbiota and the death of intestinal cells caused by chemotherapy can enhance the immune response of people with colon cancer.
Researchers have found that the community of bacteria in a person’s gut can alter how well they metabolize drugs.
Researchers have found that alterations of the vaginal microbiota are associated with the success of in-vitro fertilization.
